Healthcare
Hands on Training icon
Hands On Training
Hands on Training icon

Making a Cell Therapy: Principles and Practice of Manufacturing

Course Cover
compare button icon

Course Features

icon

Duration

9 weeks

icon

Delivery Method

Online

icon

Available on

Limited Access

icon

Accessibility

Mobile, Desktop, Laptop

icon

Language

English

icon

Subtitles

English

icon

Level

Intermediate

icon

Effort

7 hours per week

icon

Teaching Type

Self Paced

Course Description

The success of CAR-T cell therapies, driven by their unprecedented efficacy and recent regulatory approvals, has kick-started a new wave of interest into cells as therapies. Yet manufacturing is the link between an exciting new development in the laboratory and a commercial therapy available to the patients who need it. This course will introduce learners to this new field through the following topics.

  • Cellular therapies are living products that are only effective when delivered alive. This course will introduce the basic cellular biology that controls cellular growth and metabolism.
  • The enhanced function of some cell therapies relies on our ability to genetically engineer the cells. This course will teach the current and emerging approaches that are used for genetic modification.
  • This course will teach how we isolate cells from patients or donors and then manipulate them, including helping those cells to grow and multiply outside of the body, to produce a living product at a therapeutically relevant dose.
  • We also need to have confidence that the product we have made is safe and effective and that the process we have used to make it did not encounter any unanticipated obstacles along the way. This course will teach some of the analytical methods used to do this and why these methods were chosen.
  • As these are often individualized therapies, how do you reproducibly manufacture a highly complex living therapy for all of the patients who may need it? This course will teach about the unique characteristics of cell therapies and how those characteristics drive manufacturing, delivery, and supply chain decisions.
  • Cell therapies are part of the larger pharmaceutical industry, which operates under regulatory oversight. This course will teach about how drugs are regulated and how those regulations are applied specifically to cellular therapies.

This course is intended to provide an overview of the key concepts needed to manufacture a cell therapy for learners interested in entering this exciting new field.

Course Overview

projects-img

International Faculty

projects-img

Post Course Interactions

projects-img

Instructor-Moderated Discussions

Skills You Will Gain

Prerequisites/Requirements

Cell Biology

What You Will Learn

Analytics for cell therapy

Cell biology and immunology

Cell therapy manufacturing practices

Industrialization of cell therapies

Regulatory requirements for cell therapies

Course Instructors

Author Image

Caleb Neufeld

Research Scientist at Massachusetts Institute of Technology

Caleb began his research career developing cell therapies at UCLA. After graduate work at Tufts, Caleb joined the MIT Center for Biomedical Innovation to help advance biomanufacturing and biotherapeutic access.
Author Image

Jacqueline M. Wolfrum

Co-Director, Biomanufacturing Program at Massachusetts Institute of Technology

Dr. Jacqueline M. Wolfrum is the Co-Director of the Biomanufacturing Program at MIT’s Center for Biomedical Innovation (CBI), where her work includes managing sponsored research programs and advancin...
Author Image

Krystyn Van Vliet

Vice President for Research & Innovation; Professor, Department of Materials Science & Engineering and Meinig School of Biomedical Engineering at Cornell University

Prof. Van Vliet earned her Sc.B. in Materials Science & Engineering from Brown University (1998) and her PhD in Materials Science & Engineering from MIT (2002). Van Vliet joined MIT’s Department of M...
Author Image

Michael Birnbaum

Class of 1956 Career Development Professor, Biological Engineering at Massachusetts Institute of Technology

Prof. Birnbaum obtained an A.B. in Chemical and Physical Biology at Harvard University in 2008. He then moved to Stanford University, where he completed his Ph.D. in Immunology in 2014. At Stanford, ...
Course Cover